Stocksigma LogoStocksigma Logo

US FDA Classifies Aurobindo Pharma's Lannett Facility as Official Action Indicated

The US FDA has classified the inspection of Lannett Company LLC—a wholly owned step-down subsidiary of Aurobindo Pharma located in Seymour, Indiana—as

US FDA Classifies Aurobindo Pharma's Lannett Facility as Official Action Indicated

Aurobindo Pharma Ltd · Others (Uncategorized) · 12 Nov 2026, 2:04 am

US FDA Classifies Aurobindo Pharma's Lannett Facility as Official Action Indicated The US FDA has classified the inspection of Lannett Company LLC—a wholly owned step-down subsidiary of Aurobindo Pharma located in Seymour, Indiana—as "Official Action Indicated" (OAI). The facility was inspected between 17th Aug'26 and 21st Aug'26, resulting in four observations to which the company previously responded. Aurobindo Pharma received the OAI communication on 11th Nov'26. The company stated that this classification has no quantifiable monetary or operational impact on its financials or business activities.

Original exchange filing (PDF)

More announcements from Aurobindo Pharma Ltd

All Aurobindo Pharma Ltd announcements